Pharmacokinetics and metabolism of 14C-oxaceprol in beagle dogs after intramuscular and oral administration.
Blood and plasma levels and renal and faecal excretion of 14C-oxaceprol (N-acetyl-4-hydroxyproline, AHP 200) were measured after p.o. and after i.m. administration to 3 male Beagle dogs each. In addition, the concentration of 14C-oxaceprol equivalents in synovia was determined at tmax and at tmax + t1/2(elim.). The pattern of metabolites was investigated for plasma, synovia, and urine samples. Peak plasma levels were obtained for the individual animals between 20 and 30 min after i.m. administration and between 2 and 2.5 h after p.o. administration, respectively. The concentrations of 14C-oxaceprol equivalents in synovia 2.5 and 3.5 h after oral administration and 1.3 h after i.m. administration were comparable to the respective plasma levels at the same time. After oral administration the amount of absorbed oxaceprol varied between 43 and 79% of the dose. Oxaceprol was exclusively eliminated via the kidneys. Excretion was complete within 72 h p.a. for both administration routes. Elimination half-lives were 44 +/- 9 min. or 68 +/- 14 min. (means +/- S.D.) after i.m. and p.o. administration, respectively. Oxaceprol was not metabolized.
Lachmann
G
G
Battelle-Institut e.V., Abteilung Pharmakologie und Toxikologie, Frankfurt, Main, Fed. Rep. of Germany.
Siegemund
B
B
Kusche
W
W
D000284:Administration, Oral; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*; D004285:Dogs; D005243:Feces / Q000032:analysis; D006909:Hydroxyproline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D007273:Injections, Intramuscular; D008297:Male; D013582:Synovial Fluid / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; C012393:oxaceprol; D006909:Hydroxyproline